Rchr
J-GLOBAL ID:201801003871329335   Update date: May. 23, 2024

Isobe Taichi

イソベ タイチ | Isobe Taichi
Affiliation and department:
Other affiliations (1):
Research field  (3): Hematology and oncology ,  Tumor diagnostics and therapeutics ,  Tumor biology
Research theme for competitive and other funds  (3):
  • 2021 - 2024 Characterization of immune responses in tumor microenvironment of patients with clonal hematopoiesis
  • 2019 - 2021 Establishment of a new model for human colorectal cancers
  • 2015 - 2017 Molecular basis for the establishment of early metastatic lesion through cell adaptation
Papers (35):
  • Kyoko Yamaguchi, Mamoru Ito, Taichi Isobe, Sakuya Koreishi, Ryosuke Taguchi, Koki Uehara, Shohei Ueno, Takashi Imajima, Takafumi Kitazono, Kenji Tsuchihashi, et al. Impact of Genomic Alterations on Efficacy of Trastuzumab Deruxtecan Against Human Epidermal Growth Factor Receptor-2-Positive Advanced Gastric Cancer. JCO Precision Oncology. 2024. 8
  • Shixuan Liu, Camille Ezran, Michael F. Z. Wang, Zhengda Li, Kyle Awayan, Snigdha Agarwal, Aditi Agrawal, Ahmad Al-Moujahed, Alina Alam, Megan A. Albertelli, et al. An organism-wide atlas of hormonal signaling based on the mouse lemur single-cell transcriptome. Nature Communications. 2024. 15. 1
  • Kenji Tsuchihashi, Mamoru Ito, Shuji Arita, Hitoshi Kusaba, Wataru Kusano, Takashi Matsumura, Takafumi Kitazono, Shohei Ueno, Ryosuke Taguchi, Tomoyasu Yoshihiro, et al. Survival outcomes including salvage therapy of adult head and neck para-meningeal rhabdomyosarcoma: a multicenter retrospective study from Japan. BMC Cancer. 2023. 23. 1
  • Koki Uehara, Kenro Tanoue, Kyoko Yamaguchi, Hirofumi Ohmura, Mamoru Ito, Yuzo Matsushita, Kenji Tsuchihashi, Shingo Tamura, Hozumi Shimokawa, Taichi Isobe, et al. Preferential B cell differentiation by combined immune checkpoint blockade for renal cell carcinoma is associated with clinical response and autoimmune reactions. Cancer immunology, immunotherapy : CII. 2023
  • Michitaka Nakano, Taguchi R, Kikushige Y, Taichi Isobe, Kohta Miyawaki, Mizuno S, Tsuruta N, Hanamura F, Yamaguchi K, Yamauchi T, et al. RHAMM marks proliferative subpopulation of human colorectal cancer stem cells. Cancer science. 2023
more...
MISC (51):
  • 馬場 英司, 磯部 大地, 有山 寛. パンデミックと学会活動. 腫瘍内科. 2022. 30. 6. 681-684
  • 遠藤 誠, 土橋 賢司, 松本 嘉寛, 坂本 節子, 鍋島 央, 飯田 圭一郎, 藤原 稔史, 伊東 守, 磯部 大地, 有山 寛, et al. 希少がんの治療戦略 信頼と絆に基づく肉腫のチーム医療. 日本癌治療学会学術集会抄録集. 2022. 60回. WS15-3
  • 下野 洋平, 久森 重夫, 向山 順子, 林 孝典, 前田 真男, 磯部 大地, 浅井 直也, 掛地 吉弘. 正常最終分化細胞の解析によるがん幹細胞抑制性マイクロRNAの同定(Analyses of terminally differentiated normal cells guide the identification of cancer stem cell-suppressor microRNAs). 日本癌学会総会記事. 2022. 81回. MS2-2
  • 磯部 大地, 馬場 英司. 【がん免疫療法の展望:免疫チェックポイント阻害薬の併用療法に中心に】免疫チェックポイント阻害薬の併用療法のエビデンス 免疫チェックポイント阻害薬と化学療法. 腫瘍内科. 2022. 30. 1. 8-17
  • 田ノ上 絢郎, 大村 洋文, 土橋 賢司, 篠原 雄大, 伊東 守, 山口 享子, 田村 真吾, 下川 穂積, 磯部 大地, 柴田 義宏, et al. 消化器領域におけるがん免疫療法の現状と課題 ニボルマブ治療を受けた切除不能進行食道癌患者における末梢血中の疲弊細胞の意義. 日本消化器病学会九州支部例会・日本消化器内視鏡学会九州支部例会プログラム・抄録集. 2022. 119回・113回. 93-93
more...
Work history (5):
  • 2024/04 - 現在 Kyushu Univeristy Comprehensive Oncology Assistant Professor
  • 2020/10 - 現在 九州大学病院 血液・腫瘍・心血管内科
  • 2020/10 - 2024/03 Kyushu University Graduate School of Medical Sciences Department of Oncology and Social Medicine Associate Professor
  • 2017/04 - 2018/09 Stanford University Stem Cell Institute Research Scientist
  • 2012/05 - 2017/03 Stanford University Stem Cell Institute Postdoctoral Researcher
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page